7-Year Outcomes of a Randomized Trial Comparing the First-Generation Sirolimus-Eluting Stent Versus the New-Generation Everolimus-Eluting Stent

Clinical End Points in Coronary Stent Trials

Donald E. Cutlip, Stephan Windecker, Roxana Mehran et al. · Circulation · 2007 · 5.4K citations

Medicine, Cardiology, Health Technology Assessment +13

Very Late Coronary Stent Thrombosis of a Newer-Generation Everolimus-Eluting Stent Compared With Early-Generation Drug-Eluting Stents

Lorenz Räber, Michael Magro, Giulio Stefanini et al. · Circulation · 2012 · 369 citations · Full text

Medicine, Cardiology, Cardiovascular Pharmacotherapy +13

Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trial

Giulio Stefanini, Bindu Kalesan, Patrick W. Serruys et al. · The Lancet · 2011 · 352 citations

Medicine, Cardiology, Clinical Cardiology +15

Risk of Stent Thrombosis Among Bare-Metal Stents, First-Generation Drug-Eluting Stents, and Second-Generation Drug-Eluting Stents

Tomohisa Tada, Robert A. Byrne, Iva Šimunović et al. · JACC: Cardiovascular Interventions · 2013 · 336 citations

Medicine, Cardiology, Interventional Cardiology +11

Improved Safety and Reduction in Stent Thrombosis Associated With Biodegradable Polymer-Based Biolimus-Eluting Stents Versus Durable Polymer-Based Sirolimus-Eluting Stents in Patients With Coronary Artery Disease

Patrick W. Serruys, Vasim Farooq, Bindu Kalesan et al. · JACC: Cardiovascular Interventions · 2013 · 331 citations

Medicine, Biomedical Engineering, Cardiology +14